1. Home
  2. /
  3. Availability
  4. /
  5. IGRA prevalence study

IGRA prevalence study

Description

 A cross-sectional study to determine IGRA positivity rate to assess eligibility for participation in tuberculosis (TB) vaccine efficacy trials
TB vaccine theme
Availability
Epidemiological impact

Project details

Country
Kenya, South Africa
Timeline
2024-2025
Target group
Vaccine
Type of protection of vaccine
Type of research
Quantitative
Partners involved
IAVI
Type of project
research

Resources

Epidemiology - IAVI

Contact

Puck Pelzer
ppelzer@iavi.org
Click to copy link of this headerMenu